MA49508A - Procédés de traitement d'une insuffisance cardiaque avec des activateurs de sarcomères cardiaques - Google Patents
Procédés de traitement d'une insuffisance cardiaque avec des activateurs de sarcomères cardiaquesInfo
- Publication number
- MA49508A MA49508A MA049508A MA49508A MA49508A MA 49508 A MA49508 A MA 49508A MA 049508 A MA049508 A MA 049508A MA 49508 A MA49508 A MA 49508A MA 49508 A MA49508 A MA 49508A
- Authority
- MA
- Morocco
- Prior art keywords
- sarcomera
- activators
- cardiac
- processes
- heart failure
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 title 1
- 239000012190 activator Substances 0.000 title 1
- 230000000747 cardiac effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762527983P | 2017-06-30 | 2017-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA49508A true MA49508A (fr) | 2020-05-06 |
Family
ID=63013097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA049508A MA49508A (fr) | 2017-06-30 | 2018-06-29 | Procédés de traitement d'une insuffisance cardiaque avec des activateurs de sarcomères cardiaques |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US11576910B2 (fr) |
| EP (1) | EP3645002A1 (fr) |
| JP (2) | JP2020526483A (fr) |
| CN (1) | CN110996953A (fr) |
| AU (2) | AU2018290983B2 (fr) |
| BR (1) | BR112019028046A2 (fr) |
| CA (1) | CA3068588A1 (fr) |
| MA (1) | MA49508A (fr) |
| MX (2) | MX2020000190A (fr) |
| WO (1) | WO2019006235A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA031185B1 (ru) | 2013-03-14 | 2018-11-30 | Эмджен Инк. | Гетероциклические соединения и способы их применения |
| SI3645518T1 (sl) | 2017-06-30 | 2021-11-30 | Amgen Inc. | Sinteza omekamtiv mekarbila |
| MX2020000190A (es) | 2017-06-30 | 2020-07-22 | Amgen Inc | Métodos para tratar la insuficiencia cardíaca con activadores de sarcómero cardíaco. |
| AU2019321573A1 (en) | 2018-08-17 | 2021-03-04 | Amgen Inc. | Salts and crystal forms of omecamtiv mecarbil |
| CA3200673A1 (fr) * | 2020-11-12 | 2022-05-19 | Amgen Inc. | Methodes de traitement d'insuffisance cardiaque par l'administration d'omecamtiv mecarbil |
| CA3212491A1 (fr) | 2021-03-10 | 2022-09-15 | Sebastien Caille | Synthese d'omecamtiv mecarbil |
| WO2023164452A2 (fr) * | 2022-02-22 | 2023-08-31 | Yale University | Méthodes de traitement, d'atténuation ou de prévention de l'insuffisance cardiaque, et méthodes de promotion de la croissance des muscles cardiaques |
| WO2024081611A1 (fr) * | 2022-10-11 | 2024-04-18 | Cytokinetics, Incorporated | Méthodes de traitement de l'insuffisance cardiaque par administration d'activateurs de sarcomère cardiaque |
| US11986474B1 (en) | 2023-06-27 | 2024-05-21 | Cytokinetics, Incorporated | Methods for treating heart failure by administering cardiac sarcomere activators |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4450150A (en) | 1973-05-17 | 1984-05-22 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery depots, and method for preparing and using the same |
| AU2546399A (en) | 1998-02-10 | 1999-08-30 | Yoshitomi Pharmaceutical Industries, Ltd. | Preparations with controlled release |
| GB2344287A (en) | 1998-12-03 | 2000-06-07 | Ferring Bv | Controlled release pharmaceutical formulation |
| EP1551505B1 (fr) | 2002-10-04 | 2010-02-24 | Microchips, Inc. | Appareil medical pour administration controlee de medicament et surveillance et/ou stimulation cardiaques |
| EP2862859B1 (fr) | 2004-06-17 | 2018-07-25 | Cytokinetics, Inc. | Composants, compositions et procédés |
| AR058347A1 (es) | 2005-12-15 | 2008-01-30 | Cytokinetics Inc | Entidades quimias composiciones y metodos |
| JP2009537530A (ja) | 2006-05-15 | 2009-10-29 | ウィスコンシン・アルムニ・リサーチ・ファウンデーション | １α，２５−ジヒドロキシビタミンＤ３の肺送達および副甲状腺ホルモンまたはカルシトニンの同時投与 |
| FR2902092B1 (fr) | 2006-06-07 | 2008-09-05 | Sapelem Soc Par Actions Simpli | Appareil de manutention de charge |
| CN101657190B (zh) | 2007-04-19 | 2013-09-11 | 东亚制药株式会社 | 一种适用于对葡萄糖控制肽进行控释的可生物降解的微球组合物及其制剂 |
| EA031185B1 (ru) | 2013-03-14 | 2018-11-30 | Эмджен Инк. | Гетероциклические соединения и способы их применения |
| JP6634368B2 (ja) * | 2013-03-14 | 2020-01-22 | アムジエン・インコーポレーテツド | 複素環式化合物及びそれらの使用 |
| US20180022710A1 (en) | 2015-01-29 | 2018-01-25 | Signal Pharmaceuticals, Llc | Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide |
| AU2016282985B2 (en) | 2015-06-26 | 2021-07-29 | Amgen Inc. | Combination therapy of cardiac myosin activator and sinus node if current inhibitor |
| SI3645518T1 (sl) | 2017-06-30 | 2021-11-30 | Amgen Inc. | Sinteza omekamtiv mekarbila |
| MX2020000190A (es) | 2017-06-30 | 2020-07-22 | Amgen Inc | Métodos para tratar la insuficiencia cardíaca con activadores de sarcómero cardíaco. |
| LT3594199T (lt) | 2018-07-09 | 2020-11-10 | F.I.S.- Fabbrica Italiana Sintetici S.P.A. | Kristalinis 2-fluor-3-nitroluenas ir jo paruošimo būdas |
| WO2020014406A1 (fr) | 2018-07-12 | 2020-01-16 | Assia Chemical Industries Ltd. | Formes à l'état solide d'omecamtiv mecarbil et d'omecamtiv mecarbil dihcl |
| AU2019321573A1 (en) | 2018-08-17 | 2021-03-04 | Amgen Inc. | Salts and crystal forms of omecamtiv mecarbil |
| WO2020131574A1 (fr) | 2018-12-18 | 2020-06-25 | Amgen Inc. | Procédé de réduction de composés nitro aromatiques |
| US20220340542A1 (en) | 2019-09-19 | 2022-10-27 | Synthon B.V. | Salts of omecamtiv mecarbil and solid forms thereof |
| WO2021053175A1 (fr) | 2019-09-19 | 2021-03-25 | Synthon B.V. | Sels d'omecamtiv mecarbil et formes solides de ceux-ci |
| US20220411374A1 (en) | 2019-10-09 | 2022-12-29 | Dr. Reddy's Laboratories Limited | Alternate processes for the preparation of omecamtiv mecarbil |
| EP4041198A4 (fr) | 2019-10-09 | 2023-08-16 | Dr. Reddy's Laboratories Limited | Formes solides de dichlorhydrate d'omecamtiv mecarbil et procédés associés |
| WO2021136477A1 (fr) | 2020-01-03 | 2021-07-08 | 苏州科睿思制药有限公司 | Co-cristal de dichlorhydrate du composé i et son procédé de préparation et son utilisation |
| CN115279349A (zh) | 2020-02-10 | 2022-11-01 | 安进股份有限公司 | 奥美卡替莫卡必尔片剂 |
| CA3200673A1 (fr) | 2020-11-12 | 2022-05-19 | Amgen Inc. | Methodes de traitement d'insuffisance cardiaque par l'administration d'omecamtiv mecarbil |
| CA3212491A1 (fr) | 2021-03-10 | 2022-09-15 | Sebastien Caille | Synthese d'omecamtiv mecarbil |
| WO2023205291A2 (fr) | 2022-04-21 | 2023-10-26 | The Board Of Regents Of The University Of Oklahoma | Ciblage de tissu myocardique pour l'administration d'agents thérapeutiques et d'imagerie |
-
2018
- 2018-06-29 MX MX2020000190A patent/MX2020000190A/es unknown
- 2018-06-29 AU AU2018290983A patent/AU2018290983B2/en active Active
- 2018-06-29 MA MA049508A patent/MA49508A/fr unknown
- 2018-06-29 CA CA3068588A patent/CA3068588A1/fr active Pending
- 2018-06-29 BR BR112019028046-4A patent/BR112019028046A2/pt active Search and Examination
- 2018-06-29 EP EP18745732.0A patent/EP3645002A1/fr active Pending
- 2018-06-29 US US16/625,958 patent/US11576910B2/en active Active
- 2018-06-29 CN CN201880053343.0A patent/CN110996953A/zh active Pending
- 2018-06-29 WO PCT/US2018/040181 patent/WO2019006235A1/fr active Application Filing
- 2018-06-29 JP JP2019570045A patent/JP2020526483A/ja active Pending
-
2020
- 2020-01-08 MX MX2022015115A patent/MX2022015115A/es unknown
-
2023
- 2023-01-17 US US18/155,483 patent/US20230149394A1/en active Pending
- 2023-03-15 JP JP2023040600A patent/JP2023088944A/ja active Pending
- 2023-05-05 US US18/313,267 patent/US11931358B2/en active Active
-
2024
- 2024-02-15 AU AU2024200991A patent/AU2024200991A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US11931358B2 (en) | 2024-03-19 |
| JP2020526483A (ja) | 2020-08-31 |
| US20200155547A1 (en) | 2020-05-21 |
| CA3068588A1 (fr) | 2019-01-03 |
| MX2022015115A (es) | 2023-01-18 |
| EP3645002A1 (fr) | 2020-05-06 |
| AU2024200991A1 (en) | 2024-03-07 |
| US11576910B2 (en) | 2023-02-14 |
| US20230149394A1 (en) | 2023-05-18 |
| AU2018290983B2 (en) | 2023-11-23 |
| WO2019006235A1 (fr) | 2019-01-03 |
| JP2023088944A (ja) | 2023-06-27 |
| CN110996953A (zh) | 2020-04-10 |
| US20230355615A1 (en) | 2023-11-09 |
| AU2018290983A1 (en) | 2020-01-23 |
| BR112019028046A2 (pt) | 2020-07-07 |
| MX2020000190A (es) | 2020-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA49508A (fr) | Procédés de traitement d'une insuffisance cardiaque avec des activateurs de sarcomères cardiaques | |
| MA50056A (fr) | Procédés de traitement de tumeur | |
| ZA202006636B (en) | Use of sublingual dexmedetomidine for the treatment of agitation | |
| PH12017502107A1 (en) | Triazole agonists of the apj receptor | |
| MA45192A (fr) | Traitement d'association | |
| HK1253734A1 (zh) | 用作RORγ激動劑和用於治療疾病的芳基二氫-2H-苯並[B][1，4]噁嗪磺酰胺和相關化合物 | |
| MA51815A (fr) | Méthodes de traitement ou de prévention de migraines avec anticorps contra le receptor de cgrp | |
| JP2016028092A5 (fr) | ||
| DK3364997T3 (da) | Aspartoacylase genterapi til behandling af canavans sygdom | |
| JP2016065085A5 (fr) | ||
| WO2015142001A3 (fr) | Composé doté d'une action cardiotonique et composition pharmaceutique permettant de prévenir ou de traiter l'insuffisance cardiaque et contenant ledit composé | |
| BR112018005499A2 (pt) | métodos de tratamento de pressão intraocular com ativadores de tie-2. | |
| PH12017550023A1 (en) | A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders | |
| MA43106A (fr) | Traitement de l'oligo-ovulation associée à la stéatose hepatique | |
| GB201612165D0 (en) | Combinations for the treatment of type 2 diabetes | |
| MA42611A (fr) | Traitement combiné comprenant l'administration de 2-amino-3,5,5-trifluoro-3,4,5,6-tétrahydropyridines | |
| PL3484475T3 (pl) | 1-Metylonikotynamid do leczenia choroby układu krążenia | |
| MA55515A (fr) | Procédés de traitement de la dystrophie musculaire avec casimersen | |
| IL274843A (en) | A system for biological water treatment | |
| TR201907044T4 (tr) | Yeni bileşikler. | |
| GB2588904B (en) | Improvements in, or relating to, the treatment of by-products | |
| TR201905436T4 (tr) | Terapötik bileşikler olarak yeni ep4 agonistleri. | |
| IT201700051827A1 (it) | Macchina per il trattamento di tessuti stampati in falde | |
| BR112017024619A2 (pt) | tratamento de tecidos e têxteis. | |
| FR3022567B1 (fr) | Cuve de traitement d'eaux |